Liquid Biopsy: A Multi-Parametric Analysis of Mutation Status, Circulating Tumor Cells and Inflammatory Markers in <i>EGFR</i>-Mutated NSCLC
The liquid biopsy has the potential to improve patient care in the diagnostic and therapeutic setting in non-small cell lung cancer (NSCLC). Consented patients with epidermal growth factor receptor (<i>EGFR</i>) positive disease (<i>n</i> = 21) were stratified into two cohort...
| 发表在: | Diagnostics |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| 格式: | 文件 |
| 语言: | 英语 |
| 出版: |
MDPI AG
2022-09-01
|
| 主题: | |
| 在线阅读: | https://www.mdpi.com/2075-4418/12/10/2360 |
